MaxCyte shareholders back directors, auditor
MaxCyte, Inc. held its 2026 annual stockholder meeting on June 17, 2026, where investors voted on board composition and the company’s auditor.
Rhea-AI Filing Summary
MaxCyte, Inc. held its 2026 annual stockholder meeting on June 17, 2026, where investors voted on board composition and the company’s auditor. Stockholders elected three Class II directors: Patrick Balthrop, Cynthia Collins and Stanley Erck, each receiving more votes for than withheld.
Investors also ratified the Audit Committee’s selection of CohnReznick LLP as MaxCyte’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with over 70 million votes cast in favor and minimal opposition or abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Submission of Matters to a Vote of Security Holders regulatory
Broker Non-Votes financial
independent registered public accounting firm financial
Emerging growth company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which directors were elected at MaxCyte (MXCT)’s 2026 annual meeting?
How strong was support for MaxCyte (MXCT)’s auditor ratification in 2026?
What were the vote results for MaxCyte (MXCT) director nominee Cynthia Collins?
What were the broker non-votes in MaxCyte (MXCT)’s 2026 director elections?
AI-generated analysis. How Rhea-AI works. Not financial advice.